Working within the pharmaceutical industry for over 20 years, Andrew specializes in leading the development, management, design, and delivery of a range of strategic projects at the brand and franchise level. Andrew’s depth of experience in facilitating strategic decisions across teams and optimizing strategy development is supported by prior roles at Phasic Strategy, Datamonitor’s Strategic Planning group, and the Pharma and Biotech Consulting team at Wood Mackenzie. Prior to consulting roles, he spent four years in Research and Development at Pfizer UK gaining valuable experience in preclinical research and early product development.

Andrew holds two degrees from the University of Glasgow – a PhD in Chemistry and a BSc (Hons) in Medicinal Chemistry.

When not working, Andrew can be found enjoying the outdoors in upstate New York.